Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Inhibitor of Bcl-2, Bcl-X(L) and Bcl-w
ENZ-CHM203-0001 1 mg 60.00 USD
ENZ-CHM203-0005 5 mg 109.00 USD
Do you need bulk/larger quantities?
ABT-737 is a small-molecule inhibitor of the anti-apoptotic proteins Bcl-2, Bcl-X(L) and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compounds. Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation. ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumors, and produces cures in a high percentage of the mice. ABT-737 binds to Bcl-2, Bcl-xL and Bcl-w with very high affinities (Ki <1 nM) and also shows a very high specificity over Mcl-1 and A1.

Product Specification

Alternative Name:4-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl] sulfonylbenzamide
Purity:≥98% (HPLC)
Identity:Determined by EM-MS, NMR
Appearance:Yellow powder.
Solubility:Soluble in DMSO (24mg/ml) or ethanol (<1mg/ml).
Short Term Storage:+4°C
Long Term Storage:-20°C
ENZ-CHM203 structure
Please mouse over
ENZ-CHM203 structure

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2018 Enzo Life Sciences, Inc.,